Kanoria Chemicals Q4 FY26 Results: PAT Rs 32 Cr

Kanoria Chemicals Q4 FY26 results were declared on May 25, 2026. The company reported PAT of Rs 32 crore for the quarter ended March 31, 2026, up 180.0% YoY compared to loss of Rs 40 crore in Q4 FY25. Revenue from operations was Rs 304 crore, down 29.5% YoY. Results are on a Consolidated basis. Kanoria Chemicals is a Specialty Chemicals company listed on Indian stock exchanges.

Click Here – Get Free Investment Predictions

Kanoria Chemicals Q4 FY26 Financial Highlights

Metric	Q4 FY26 (Rs Cr)	Q4 FY25 (Rs Cr)	YoY Change
Revenue	Rs 304 crore	Rs 431 crore	-29.5%
Net Profit	32	40	+180.0%
Basis	Consolidated

Note: Kanoria Chemicals Q4 FY26 results declared May 25, 2026. Data sourced from Screener.in BSE filings. Verify from audited statements before investment decisions.

Kanoria Chemicals Q4 FY26 Performance Analysis

The Kanoria Chemicals Q4 FY26 results reflect the company’s financial performance during the January to March 2026 quarter. The quarter shows strong profitability growth of 180% YoY, reflecting improved operational execution. Kanoria Chemicals operates in the Specialty Chemicals sector, which benefits from India’s GDP growth above 6.5% in FY26.

Revenue of Rs 304 crore was down 29.5% YoY. Revenue moderation reflects near-term demand headwinds.

Screen the best stocks on the Univest Screener.

Key Factors Driving Kanoria Chemicals Q4 FY26 Results

Revenue and Business Execution

Revenue of Rs 304 crore in Kanoria Chemicals Q4 FY26 was down 29.5% YoY. Revenue pressure reflects near-term demand headwinds in the Specialty Chemicals market. The January to March quarter is the fiscal year-end period characterised by strong order execution and year-end activity across Indian companies.

Profitability and Margin Trends

The the business PAT of Rs 32 crore up 180.0% YoY. Strong PAT growth demonstrates improving operational leverage and business fundamentals.

India Macro Environment Q4 FY26

India’s macroeconomic environment in Q4 FY26 was supportive with GDP growth above 6.5%, government capex of Rs 11.21 lakh crore budgeted for FY27, and resilient domestic consumption. The Reserve Bank of India’s accommodative stance supported credit conditions. The Specialty Chemicals sector benefited from these structural tailwinds during the January to March 2026 quarter.

FY27 Outlook

Following the firm results, management guidance on FY27 revenue growth, margin improvement roadmap, and capital allocation priorities will be key investor watchpoints. The Specialty Chemicals sector continues to benefit from India’s long-term structural growth story including urbanisation, infrastructure investment, and rising domestic consumption. Sustaining the strong profitability momentum will be the FY27 priority.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on the company

Investments in securities are subject to market risk. This content is for educational purposes only. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.